ANLN (Anillin) is an actin-binding protein and has reportedly been shown to be significantly upregulated in the BC, knockdown of ANLN results in G2/M phase block and reduces expression of cyclin B1 and D1, and it was also demonstrated that ANLN can promote the progression, migration, and invasion of BC (39). Here, CCNB1 is linked to breast cancer.